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The serpins SCCA1 and SCCA2 are highly expressed in the epithelium of the conducting airways, a common site of
infection by group C adenoviruses, such as human adenovirus type 2 (Ad2). Based on the common location we examined a
possible interaction between them. In vitro experiments with recombinant proteins showed that SCCA1 inhibited the viral
protease in a dose-dependent manner. Both serpins were cleaved in a manner consistent with hydrolysis within their reactive
site loop, without the formation of an SDS-resistant complex, as in the case of papain. Infection of SCCA1-expressing cells
did not result in the cleavage of SCCA1, nor was the yield of infectious virus affected as compared to SCCA1-negative
parental cells. This may be due to differential localization, the serpin being cytoplasmic and viral protease being nuclear.
Surprisingly, however, virus infection, which tends to inhibit host protein synthesis, caused a significant increase in SCCA1
expression well into the late phase of infection. © 2000 Academic Press
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Adenoviruses encode a cysteine endopeptidase
which cleaves several viral proteins in the course of virus
assembly and maturation (Weber, 1995). The enzyme is
specific for substrate sequences containing a Gly in the
P1 or P19 position, a second Gly in the P2 position and
Met, Ile, or Leu in the P4 position. Other than viral
proteins the enzyme also cleaves cytokeratins K7 and
K18, resulting in depolymerization and accelerating cell
lysis (Chen et al., 1993). Although the crystal structure of
the enzyme is unique, the architecture of the active site
closely resembles that of papain (Ding et al., 1996).
High-molecular-weight serine proteinase inhibitors
(serpins) regulate a diverse set of intracellular and ex-
tracellular processes such as complement activation,
fibrinolysis, coagulation, cellular differentiation, tumor
suppression, apoptosis, and cell migration (Gettins et al.,
1996; Wright, 1996). The ov-serpins are a subset of the
serpin superfamily and are characterized by their high
degree of homology to chicken ovalbumin, the lack of
N- and C-terminal extensions, the absence of a signal
peptide, and a Ser rather than an Asn residue at the
penultimate position. Recently two new ov-serpins,
SCCA1 and SCCA2, have been identified (Schneider et
al., 1995). Although no target proteases have been iden-
tified for these serpins, SCCA1 binds with a 1:1 stoichi-
ometry and at second-order rate constants of .105/M/sith several papain-like cysteine proteinases (cathep-
ins S, K, L, and papain itself). SCCA1 and SCCA2 are
n
m
1412% identical, but differ significantly at their reactive site
oops. SCCA1 inhibits papain-like cysteine proteases
nd SCCA2 inhibits chymotrypsin-like serine proteases.
SCCA1 was found to be highly expressed in the epi-
helium of the conducting airways, a common site of
nfection by the group C adenoviruses, particularly hu-
an adenovirus type 2 (Ad2). Based on the common
ocation and the target specificity is it possible that this
erpin is an endogenous inhibitor of the Ad2 protease
AVP)? Here we report the results of in vitro experiments
sing recombinant proteins, which suggest that rAVP
ay cleave these serpins in their reactive site loop,
esulting in reduced enzyme activity. In ex vivo experi-
ents, SCCA1 expression was increased by virus infec-
ion but the serpin was not cleaved nor was virus pro-
uction affected.
RESULTS AND DISCUSSION
ffect of serpins on adenovirus protease
In preliminary experiments purified, recombinant fu-
ion proteins of serpins rGST-SCCA1 (1 mg) or rGST-
CCA2 (1 mg) were added to the adenovirus protease
(0.5 mg rAVP) assay reaction using the fluorescent pep-
ide substrate R110. No significant change in enzyme
ctivity was observed. The experiments were repeated
sing the viral protein pVII substrate assay, and again
nzyme activity remained essentially unaffected (results
ot shown). Similar results were obtained with ovalbu-
in, a noninhibitory serpin. Because ovalbumin contains
0042-6822/00 $35.00
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142 RUZINDANA-UMUNYANA ET AL.an AVP consensus cleavage site, denatured ovalbumin
can, however, act as a competitive inhibitor at ovalbu-
min/substrate ratios of greater than 10. It is possible that
the GST fusion partner interferes with the activity of the
serpins or that the protease has a much greater affinity
for the R110 protease substrate than the serpins. For
these reasons the experiments were repeated with
rSCCA1 using a prior incubation with protease for 30 min
before the addition of the R110 substrate. Under these
conditions we observed a dose dependent decrease in
enzyme activity as the ratio of serpin to enzyme was
increased (Fig. 1). A ratio of 1 mol of serpin to 1 mol of
enzyme gave 30% inhibition. This is comparable to the
inhibition of papain by egg white cystatin, an industry
standard for efficient enzyme inhibition by a protein in-
hibitor (Barrett, 1981). The observed inhibition is unlikely
to be nonspecific because in a similar experiment
ovalbumin did not show any inhibitory activity, but in-
FIG. 1. Effect of rSCCA1 on protease activity. rAVP (0.5 mg) was
preincubated for 30 min with different amounts of rSCCA1 before the
addition of R110 substrate and further incubation for 2 h. The fluores-
cence units of the cleaved substrate is expressed in percentage as the
mean of six independent determinations. (Inset) A similar experiment
with ovalbumin as control.stead moderately stimulated protease activity, possibly
by stabilizing or buffering the enzyme (Fig. 1, inset).Serpins may be cleaved by adenovirus protease
So far only two cellular proteins, cytokeratins K7 and
K18, have been shown to be digested by AVP in the
course of infection (Chen et al., 1993). Digestion occurred
at the single AVP site present in both cytokeratins. Nei-
ther SCCA serpins contain AVP concensus cleavage
sites. Could the SCCA serpins be substrates for AVP
within their reactive site loop (RSL)? The results summa-
rized in Fig. 2 show that, indeed, both rGST-SCCA1 and
rGST-SCCA2 were digested by AVP. Although a variety of
digestion conditions were explored, the degree of diges-
tion was variable in extent, but not site, and never com-
plete. rGST contains an AVP site (MLGG) at residue 84.
This site was digested relatively inefficiently in rGST
alone (Fig. 2, lanes j, k) when compared to the rapid
appearance of the largest and dominant digestion prod-
uct in rGST-SCCA1 and rGST-SCCA2 (band “a” in lanes
d–e and g–h). An analysis of all the digestion products
suggests that the primary cleavage takes place at the
serpin RSL generating band “a” consisting of approxi-
mately 578 residues. When serpins act as substrates,
limited proteolysis of the RSL occurs, with the primary
sites of cleavage being within a domain of approximately
11 residues, from P10 to P91, where the P1 position repre-
ents the cleavage site for the normal target protease
Gettins et al., 1996). Consequently, in this case the exact
size of band “a” is not known.
To verify the cleavage in the serpin RSL we digested
the rGST-SCCA1 fusion protein with thrombin followed by
digestion with rAVP. Thrombin digestion yielded the ex-
pected fragments of 390 (band “d”) and 226 (band “f”)
residues and AVP digestion generated the expected sub-
fragment of approximately 352 (band “e”) residues (Fig. 2,
lanes l, m) due to presumed digestion in the RSL. Finally,
we purified rSCCA1 after thrombin digestion of the fusion
protein and subjected this pure rSCCA1 to rAVP diges-
tion. The conversion of band “d” to band “e” (lanes o, p)
supports the contention of digestion of rSCCA1 in the
RSL region by rAVP.
As evident from Fig. 2, no higher molecular weight
bands, representing SDS and heat-stable complexes
such as the SCCA1–chymotrypsin complex, were de-
tected after hydrolysis of the rSCCA serpins (Nawata et
al., 1995). Papain apparently also fails to form such a
complex after cleaving SCCA1 (Nawata et al., 1997).
Although rAVP was relatively pure, it remains possible
that some or all of the observed cleavages were due to
a contaminating protease which copurified with rAVP.
Consequently a series of control experiments were car-
ried out to examine this possibility. The following control
experiments argue against this possibility: (a) most of the
visible contaminants were 10 kDa or less, whereas pro-
teases tend to be at least 20 kDa or larger in size, (b)
rAVP only cleaved the known substrate proteins in a
e as fr
tive or
w
143ADENOVIRUS ENDOPEPTIDASE AND SERPINSmixture of viral and cellular proteins, (c) cleavage activity
was only inhibited by cysteine protease-specific inhibi-
tors and not by serine protease-specific inhibitors, (d) a
mutant rAVP (C104G/C122G with 0 activity; Rancourt et
al., 1996) purified identically did not show any cleavage
activity (Fig. 3). It might also be argued that a contami-
nating proteolytic activity present in the recombinant
serpins is responsible for some of the observed cleav-
ages. Overstained gels of self-incubated rSCCA1
showed no changes, thus arguing against this possibil-
ity. We therefore suggest that rAVP is responsible for the
digestion of rSCCA1 and rGST-SCCA2 in their RSL.
The effect of virus infection on SCCA1 expression
and vice versa
Virus infection generally suppresses host protein syn-
thesis. Here we wish to test if this holds true for SCCA1
FIG. 2. Specific cleavage of recombinant serpins SCCA1 and SCCA2
GST–SCCA fusion proteins, GST, and purified SCCA1 substrates (sub; 1
0, 2, or 18 h as indicated. The reactions were stopped by boiling in SDS–
in kDa. The cleavages are interpreted schematically in the lower figur
proteins and the thin line the serpin portion. The numbers indicate naand more particularly whether SCCA1 is potentially
cleaved by the viral protease during infection. The resultsclearly show that SCCA1 is not suppressed in the recom-
binant cell line, but increased significantly during infec-
tion under a variety of conditions (Figs. 4A–4C). SCCA1
expression remained unchanged in cells mock-infected
for 2 or 3 days (results not shown). There was no evi-
enovirus protease. A 12% polyacrylamide–SDS gel stained with silver.
ere incubated (incub) with AVP enzyme (A; 0.02 mg) or thrombin (T) for
solution. Lane a contains adenovirus type 2 as marker proteins labeled
agments a–g. The thick line designates the GST portion of the fusion
postcleavage C-terminal residues.
FIG. 3. Mutant protease does not cleave SCCA1. rSCCA1 (0.5 mg)
as incubated for 18 h with 0, 0.02, 0.2, and 1 mg (lanes b–e, respec-
tively) of a mutant rAVP purified identically to the wild type enzyme andby ad
mg) w
lysingthe reaction mixtures separated by SDS–PAGE and stained with silver.
Lane “a” contained 1 mg of rAVP only.
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Cell lysates were subjected to SDS–PAGE, blotted, and reacted with
anti-SCCA1 serum followed by 125I-labeled protein A.
M
M
M
S
b Hexon expression estimated from SDS–PAGE of cell lysates stained with
c Cells were infected with 10 PFU/cell for the indicated times, plated, and c
144 RUZINDANA-UMUNYANA ET AL.dence of SCCA1 cleavage under any of these conditions.
Lack of cleavage may be due to compartmentalization in
that SCCA1 is in the cytoplasm and active protease
within virus particles. Increased SCCA1 expression dur-
ing virus infection could be due to several mechanisms
including an increased half-life or increased gene ex-
pression or both. In an attempt to study this problem we
also looked at the effect of infection on the expression of
the endogenous SCCA1 gene in SKGIIIa cells. The re-
sults did not show any change in the expression of
SCCA1 during the course of virus infection (Fig. 4D). The
increased SCCA1 expression subsequent to infection of
the MDA-435/S1-3 cell line may therefore be due to
stimulation of the artificial promoter (EF-1a) in this trans-
ormed cell line.
A possible effect of the serpins on the course of virus
nfection was also examined. SCCA1 expression did not
ave any noticeable effect on the synthesis of infectious
irus (Table 1). Virus titers of the parental MDA-MB-435
ell line, which does not express SCCA1, and the SCCA1-
xpressing transformed derivative cell line MDA-435/
1-3 were the same. The absence of any correlation
etween SCCA1 expression and ability to support virus
eplication also extended to such other human cancer
ell lines as Hep2, MCF7, and SKGIIIa. The low virus
iters in these cell lines, relative to the Hep2 cell line,
rompted us to verify the efficiency of infection by esti-
ating the production of the major capsid protein hexon.
his showed some variability among the cell lines, but
id not affect the conclusion with regard to the indepen-
irus Infection
iter 3 105
(PFU/ml)
Hexon
expressionb (%)
Colony formation
assayc (%)
0 0 3.6
8600 50 ,0.03
67000 100 ,0.03
0 0 4.5
8 0 ,0.05
16 8
0 0 9
4 2 ,0.05
16 40 ,0.05
0
530
270
0 0 5.8
0.003 ,0.05
0.8 ,0.05
3 40
3 50
7 60FIG. 4. Immunoblot of SCCA1 expression in adenovirus infected
cells. MDA-435/S1-3 cells were infected with 5 (A) or 50 (B and C)
PFU/cell for 0, 2, or 3 days at 37°C (A and B) or 39°C (C). SKGIIIa cells
were infected for 0, 2, or 3 days at 37°C with 50 PFU/cell at 37°C (D).TABLE 1
Effect of SCCA1 on V
Cell line
Infection
(days)
SCCA1
expressiona
T
HEP2 0 2
2 2
3 2
DA-MB-435S 0 2
2 2
3 2
DA-435/S1-3 0 1
2 111
3 11
CF 7 0 2
2 2
3 2
KGIIIa 0 1
1 1
2 1
3 1
4 1
5 1
a Relative expression estimated from Western blots.
Coomassie blue.
olonies counted 2 weeks later.
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145ADENOVIRUS ENDOPEPTIDASE AND SERPINSdence of virus production from serpin expression. The
efficiency of infection was also verified by colony forma-
tion assay, based on the observation that infected cells
fail to attach and divide (Table 1). In agreement with virus
and hexon production, the data suggest that more than
99% of the cells of each cell line tested were infected by
virus. In summary, these experiments are in agreement
therefore, with the foregoing conclusion that the viral
protease does not encounter and inhibit or cleave
SCCA1.
MATERIALS AND METHODS
Enzyme and assays
Recombinant adenovirus type 2 protease (rAVP;
EC3.4.22.–) was purified by chromatography from an
Escherichia coli expression system (pLPV) as described
before (Keyvani-Amineh et al., 1995). This enzyme has 14
foreign amino acids fused to the N-terminus. This fusion
peptide has no detectable effect on the properties of the
enzyme, as determined by comparison with rAVP without
this extension or enzyme isolated from virus particles.
Enzyme activity was measured with a fluorescent pep-
tide substrate, R110, purchased from Molecular Probes,
Inc. (Eugene, OR), essentially as described before (Diouri
et al., 1995). The reaction mixture contained TE buffer (10
mM Tris–HCl, pH 8, 1 mM EDTA), 40 mM pVIc (oxidized
enzyme activating peptide GVQSLKRRRCF), 3.3 mM R110,
and 1 mg of rAVP, unless otherwise indicated, in a total
volume of 300 ml. Incubation was at 37°C for 18 h and the
luorescence was measured. In the case of protein sub-
trates (SCCA1, etc.), unless otherwise indicated, the
eaction mixture contained 1 mg substrate, 0.02 mg rAVP
in a total volume of 60 ml. The latter reactions were
topped by boiling in lysing solution.
Qualitative assays were done as described before
ith substrates of ts1-infected cell lysates labeled with
35S]methionine at the nonpermissive temperature (39°C)
t 24 h p.i. as a source of viral precursor proteins,
articularly PVII (Keyvani-Amineh et al., 1995). Endoge-
ous protease activity was inactivated by boiling this
ubstrate for 2 min. Enzyme activity is assessed from the
onversion of PVII to VII visualized on autoradiograms of
DS–PAGE separations.
Thrombin was from Sigma and used as per the man-
facturer’s instructions (0.01 Units/mg substrate).
Serpins
Recombinant human SCCA1 and SCCA2 were purified
as GST-fusion proteins as described previously (Schick
et al., 1997). Recombinant SCCA1 was also purified from
yeast (generously supplied by P. Pemberton). Purity of
these proteins was determined by SDS–PAGE and visu-
alized by silver staining. Protein concentration was de-termined by the Bradford assay (Bio-Rad). Ovalbumin
(crystallized, grade VII) was purchased from Sigma.
Cells and virus
Hep2, a human epidermoid carcinoma of the larynx,
MCF7, a human breast adenocarcinoma, and MDA-MB-
435S, a human breast ductal adenocarcinoma, cell lines
were obtained from ATCC (Rockville, MD). The MDA-435/
S1-3 cell line is a recombinant cell line obtained by
transforming the MDA-MB-435S line with a plasmid car-
rying the SCCA1 cDNA under the control of the EF-1a
promoter and a hygromycin B resistance gene. SKGIIIa is
a carcinoma cell line derived from the cervix which
expresses both SCCA1 and SCCA2. All cell lines were
cultured in DMEM medium and 10% fetal calf serum. The
MDA-435/S1-3 cell line was grown in the presence of
500 mg/ml hygromycin B (Gibco). Human adenovirus type
2 (Ad2) was grown in HEp2 cells and titered by either
plaque formation or end-point dilution in HEp2 cells. All
experiments were done at an m.o.i. of 10 PFU/cell.
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